Literature DB >> 11997671

Role of the CC chemokine receptor 9/TECK interaction in apoptosis.

B-S Youn1, K-Y Yu, J Oh, J Lee, T-H Lee, H E Broxmeyer.   

Abstract

Chemokine receptors are members of the G protein coupled receptor (GPCR) supergene family whose expression is highly restricted to hematopoietic cells. Although the primary role of chemokine and chemokine receptor interaction is believed to be regulation of chemotaxis of leukocytes, subsequent information clearly suggests that multiple immune regulatory functions are attributed to chemokine receptor signaling. We recently showed that activation of the CC chemokine 9 receptor (CCR9), a thymus-specific chemokine receptor, led to potent cFLIP(L)-independent resistance to cycloheximide-induced apoptosis and modest resistance to Fas-mediated apoptosis possibly via activation of multiple signaling components involving Akt and glycogen synthase kinase 3beta. The fact that these two apoptotic signals involve activation of similar arrays of death execution machinery such as caspase-8, caspase-9, or caspase-3, suggests that chemokine receptor signaling may provide a wide range of antiapoptotic activities to hematopoietic cells under certain biological conditions. GPCR is a large family of cell surface receptors, many of which are critically involved in hormonal and behavioral control. Recent observations also suggest that GPCR signaling plays a pivotal role in immune cell activation. Heterotrimeric G protein is an integral part of GPCR signaling. Thus, dissection of signaling components involved in the CCR9-mediated antiapoptosis could be a framework for cell survival mechanisms and may provide options for therapeutic interventions for neurdegenerative diseases or T cell malfunctioning.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997671     DOI: 10.1023/a:1015320321511

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  12 in total

1.  Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.

Authors:  William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Eve Pickering; Max Kuhn; Yu Chen; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2010-03-16       Impact factor: 17.088

Review 2.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.

Authors:  Crystal Johnson-Holiday; Rajesh Singh; Erica Johnson; Shailesh Singh; Cecil R Stockard; William E Grizzle; James W Lillard
Journal:  Int J Oncol       Date:  2011-02-23       Impact factor: 5.650

4.  Pituitary-ovary-spleen axis in ovulation.

Authors:  Oliver R Oakley; Michele L Frazer; CheMyong Ko
Journal:  Trends Endocrinol Metab       Date:  2011-05-18       Impact factor: 12.015

5.  Association between decreased CXCL12 and CCL25 expression and increased apoptosis in lymphoid tissues of cynomolgus macaques during SIV infection.

Authors:  Shulin Qin; Yongjun Sui; Michael A Murphey-Corb; Todd A Reinhart
Journal:  J Med Primatol       Date:  2008-12       Impact factor: 0.667

6.  Changes in cell migration-related molecules expressed by thymic microenvironment during experimental Plasmodium berghei infection: consequences on thymocyte development.

Authors:  Jacy Gameiro; Patrícia R A Nagib; Carolina F Andrade; Déa M S Villa-Verde; Suse D Silva-Barbosa; Wilson Savino; Fábio T M Costa; Liana Verinaud
Journal:  Immunology       Date:  2009-09-09       Impact factor: 7.397

7.  Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.

Authors:  Shulin Qin; Cynthia R Klamar; Beth A Fallert Junecko; Jodi Craigo; Deborah H Fuller; Todd A Reinhart
Journal:  Cytokine       Date:  2013-01-27       Impact factor: 3.861

Review 8.  Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors.

Authors:  Xue-Song Wu; Anke S Lonsdorf; Sam T Hwang
Journal:  J Invest Dermatol       Date:  2009-02-26       Impact factor: 8.551

9.  CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.

Authors:  Crystal Johnson-Holiday; Rajesh Singh; Erica L Johnson; William E Grizzle; James W Lillard; Shailesh Singh
Journal:  World J Surg Oncol       Date:  2011-05-03       Impact factor: 2.754

Review 10.  Multiple roles for chemokines in the pathogenesis of SIV infection.

Authors:  Todd A Reinhart; Shulin Qin; Yongjun Sui
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.